Identification of vulnerable non-culprit lesions by coronary computed tomography angiography in patients with chronic coronary syndrome and diabetes mellitus

Background Among patients with diabetes mellitus (DM) and chronic coronary syndrome (CCS), non-culprit lesions (NCLs) are responsible for a substantial number of future major adverse cardiovascular events (MACEs). Thus, we aimed to establish the natural history relationship between adverse plaque characteristics (APCs) of NCLs non-invasively identified by coronary computed tomography angiography (CCTA) and subsequent MACEs in these patients. Methods Between January 2016 and January 2019, 523 patients with DM and CCS were included in the present study after CCTA and successful percutaneous coronary intervention (PCI). All patients were followed up for MACEs (the composite of cardiac death, myocardial infarction, and unplanned coronary revascularization) until January 2022, and the independent clinical event committee classified MACEs as indeterminate, culprit lesion (CL), and NCL-related. The primary outcome was MACEs arising from untreated NCLs during the follow-up. The association between plaque characteristics detected by CCTA and primary outcomes was determined by Marginal Cox proportional hazard regression. Results Overall, 1,248 NCLs of the 523 patients were analyzed and followed up for a median of 47 months. The cumulative rates of indeterminate, CL, and NCL-related MACEs were 2.3%, 14.5%, and 20.5%, respectively. On multivariate analysis, NCLs associated with recurrent MACEs were more likely to be characterized by a plaque burden >70% [hazard ratio (HR), 4.35, 95% confidence interval (CI): 2.92–6.44], a low-density non-calcified plaque (LDNCP) volume >30 mm3 (HR: 3.40, 95% CI: 2.07–5.56), a minimal luminal area (MLA) <4 mm2 (HR: 2.30, 95% CI: 1.57–3.36), or a combination of three APCs (HR: 13.69, 95% CI: 9.34–20.12, p < 0.0001) than those not associated with recurrent MACEs. Sensitivity analysis regarding all indeterminate MACEs as NCL-related ones demonstrated similar results. Conclusions In DM patients who presented with CCS and underwent PCI, half of the MACEs occurring during the follow-up were attributable to recurrence at the site of NCLs. NCLs responsible for unanticipated MACEs were frequently characterized by a large plaque burden and LDNCP volume, a small MLA, or a combination of these APCs, as determined by CCTA.

[1]  N. Frey,et al.  Coronary Computed Tomography vs. Cardiac Magnetic Resonance Imaging in the Evaluation of Coronary Artery Disease , 2022, Diagnostics.

[2]  M. Renker,et al.  Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus. , 2022, Atherosclerosis.

[3]  Seung‐Jung Park,et al.  Routine Functional Testing or Standard Care in High-Risk Patients after PCI. , 2022, The New England journal of medicine.

[4]  F. Otsuka,et al.  Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry. , 2022, Atherosclerosis.

[5]  D. Dey,et al.  Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study , 2022, The Lancet. Digital health.

[6]  Ying Jin,et al.  Validation and Comparison of PROMISE and CONFIRM Model to Predict High-Risk Coronary Artery Disease in Symptomatic and Diabetes Mellitus Patients. , 2022, Reviews in cardiovascular medicine.

[7]  U. Schoepf,et al.  Prognostic Utility of Coronary Computed Tomography Angiography-derived Plaque Information on Long-term Outcome in Patients With and Without Diabetes Mellitus , 2021, Journal of thoracic imaging.

[8]  Huixia Lu,et al.  Association Between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis , 2021, Circulation. Cardiovascular interventions.

[9]  Yundai Chen,et al.  Comparison of Different Investigation Strategies to Defer Cardiac Testing in Patients With Stable Chest Pain. , 2021, JACC. Cardiovascular imaging.

[10]  Y. Asaumi,et al.  Comparison of coronary atherosclerotic features in response to achieving LDL-C <55 mg/dl between non-diabetic and diabetic patients: insights from the REASSURE-NIRS registry , 2021, European Heart Journal.

[11]  Junhua Zhang,et al.  Core outcome set for stable angina pectoris in traditional Chinese medicine (COS-SAP-TCM) , 2021, Acupuncture and Herbal Medicine.

[12]  J. Granada,et al.  Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. , 2021, European heart journal.

[13]  M. Mack,et al.  Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization. , 2021, Journal of the American College of Cardiology.

[14]  ShengOlivia R. Liu,et al.  Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study , 2021, The Lancet.

[15]  F. Otsuka,et al.  The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis. , 2021, Atherosclerosis.

[16]  J. Ge,et al.  Precision medicine in coronary artery disease: Time for implementation into practice , 2021 .

[17]  D. Dey,et al.  Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging - Expert consensus document on coronary CT imaging of atherosclerotic plaque. , 2020, Journal of cardiovascular computed tomography.

[18]  L. Räber,et al.  Letter by Siontis and Räber Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)". , 2020, Circulation.

[19]  Ulf J Jensen,et al.  Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. , 2020, Journal of the American College of Cardiology.

[20]  M. E. Kooi,et al.  Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging. , 2020, European heart journal cardiovascular Imaging.

[21]  S. Rajagopalan,et al.  Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus , 2020, Circulation. Cardiovascular imaging.

[22]  R. Virmani,et al.  Vulnerable plaques and patients: state-of-the-art. , 2020, European heart journal.

[23]  Sean M. O'Brien,et al.  Initial Invasive or Conservative Strategy for Stable Coronary Disease. , 2020, The New England journal of medicine.

[24]  E. V. van Beek,et al.  Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction , 2020, Circulation.

[25]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[26]  Habib Samady,et al.  Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study , 2019, The Lancet.

[27]  V. Fuster,et al.  From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[28]  P. Libby,et al.  From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[29]  Eloisa Arbustini,et al.  Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. , 2019, European heart journal.

[30]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[31]  Charles A. Taylor,et al.  Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. , 2019, JACC. Cardiovascular imaging.

[32]  Hyuk-Jae Chang,et al.  Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.

[33]  E. V. van Beek,et al.  Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study , 2019, Journal of the American College of Cardiology.

[34]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[35]  B. Lewis,et al.  Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes: A Long-Term Observational Study. , 2019, JACC. Cardiovascular imaging.

[36]  Patrick W Serruys,et al.  Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease. , 2018, Journal of the American College of Cardiology.

[37]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[38]  Jeroen J. Bax,et al.  Coronary Atherosclerotic Precursors of Acute Coronary Syndromes. , 2018, Journal of the American College of Cardiology.

[39]  Michael T. Lu,et al.  Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial , 2018, JAMA cardiology.

[40]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[41]  H. Rashid,et al.  Computed Tomographic Coronary Angiography–Derived Plaque Characteristics Predict Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis , 2018, Circulation. Cardiovascular imaging.

[42]  M. Budoff,et al.  2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. , 2017, Journal of thoracic imaging.

[43]  H. Suryapranata,et al.  Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? , 2017, Cardiovascular Diabetology.

[44]  P. Serruys,et al.  Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT Study. , 2017, JACC. Cardiovascular imaging.

[45]  V. Fuster,et al.  Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. , 2016, Journal of the American College of Cardiology.

[46]  J. Ottervanger,et al.  Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus , 2016, Cardiovascular Diabetology.

[47]  H. Bøtker,et al.  Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions , 2016, European heart journal.

[48]  Y. Jang,et al.  Limitations of coronary computed tomographic angiography for delineating the lumen and vessel contours of coronary arteries in patients with stable angina. , 2015, European heart journal cardiovascular Imaging.

[49]  D. Berman,et al.  Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography. , 2015, European heart journal cardiovascular Imaging.

[50]  G. Stone,et al.  Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. , 2014, Journal of the American College of Cardiology.

[51]  W. B. Meijboom,et al.  Prognostic implications of non-culprit plaques in acute coronary syndrome: non-invasive assessment with coronary CT angiography. , 2014, European heart journal cardiovascular Imaging.

[52]  Bo Yu,et al.  In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. , 2013, Journal of the American College of Cardiology.

[53]  M. Goddard,et al.  Atherosclerotic Plaque Composition and Classification Identified by Coronary Computed Tomography: Assessment of Computed Tomography–Generated Plaque Maps Compared With Virtual Histology Intravascular Ultrasound and Histology , 2013, Circulation. Cardiovascular imaging.

[54]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[55]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[56]  Damini Dey,et al.  Automated three-dimensional quantification of noncalcified coronary plaque from coronary CT angiography: comparison with intravascular US. , 2010, Radiology.

[57]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[58]  Markus Voelter,et al.  State of the Art , 1997, Pediatric Research.